Browse by Tags
All Tags » Bloomberg (RSS)
Sorry, but there are no more tags available to filter with.
-
Aug. 3 (Bloomberg) -- Qantas Airways Ltd., Australia's largest carrier, will be subject to ``additional safety checks'' following several incidents last week, the Civil Aviation Safety Authority said today.
-
July 10 (Bloomberg) -- Intel Corp., the world's largest chipmaker, won U.S. Food and Drug Administration clearance to begin selling a medical computer designed to help the elderly manage health conditions at home.
-
July 10 (Bloomberg) -- Intel Corp., the world's largest chipmaker, won U.S. Food and Drug Administration clearance to begin selling a medical computer designed to help the elderly manage health conditions at home.
-
June 25 (Bloomberg) -- Otsuka Pharmaceutical Co. said a U.S. advisory panel backed approval of tolvaptan, the Japanese company's treatment for low concentrations of sodium in the blood.
-
June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition.
-
June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition.
-
June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition.
-
June 7 (Bloomberg) -- Bristol-Myers Squibb Co., AstraZeneca Plc and Takeda Pharmaceuticals Co.'s experimental diabetes drugs may give U.S. patients effective alternatives to Merck & Co.'s Januvia, one of the newest pills approved for the condition.
-
US Recall News (press release) Heparin in Medical Devices Linked to 11 US Deaths (Update3) Bloomberg - 4 hours ago By Justin Blum June 5 (Bloomberg) -- Eleven deaths and 86 cases of harmful side effects this year have been linked to use of medical devices containing the blood thinner ...
-
June 5 (Bloomberg) -- Eleven deaths and 86 cases of harmful side effects this year have been linked to use of medical devices containing the blood thinner heparin, U.S. regulators said.
|
|
|